AzTrials
AzTrials

Pneumonia in ChildrenNCT02941237

Development of a Robust and Reliable Pulse Oximeter for Children With Pneumonia in Low-income Countries

A study testing Pulse oximeter in people with Pneumonia in Children and Measurement of Peripheral Oxygen Saturation, run by The Lifebox Foundation at 3 sites in 3 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to test the usability of a new pulse oximeter probe designed for children 0-5 years. Read more about this study

Who is it for?
Ages Up to 5 yearsHealthy volunteers can take part
What is being tested?
Pulse oximeter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
572 participants
Where
3 sitesin 3 countries
Study dates
2 May 2017to 1 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 5 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Patient participants:
  • Inpatients (or child awaiting surgery on pre-operative ward) in Great Ormond Street Hospital, or government facilities in Malawi and Bangladesh
  • Aged 0 - 59 months
  • Clinically stable (as judged by the ward sister and medical team)
  • Parent (or adult with parental responsibility) present
  • Informed consent from the parent (or adult with parental responsibility)
Show all 9Show fewer
  • Healthcare worker participants:
  • Nursing staff employed at Great Ormond Street Hospital who are trained in the use of pulse oximetry or government healthcare providers working in Malawi and Bangladesh
  • Written informed consent from the healthcare worker

Who cannot join

  • Patient participants:
  • Unstable or critically unwell patients (as judged by their medical team)
  • Parents (or adult with parental responsibility) who are not able or willing to give informed consent
  • Parents (or adult with parental responsibility) unable to speak English well enough to understand study methods or consent form (UK only)
  • For part of the study assessing usability of the probe by healthcare workers, patients with oxygen saturation 95% or below will be excluded
  • Healthcare worker participants:
  • Healthcare providers who are not trained to use a pulse oximeter
  • Healthcare providers who have not given written informed consent

Trial locations and contacts

3 sites in 3 countries.

3 sites in 3 countries

Bangladesh1 site
  • Sylhet hospital

    Sylhet

Other trials in Bangladesh

Malawi1 site
  • District and referral hospitals

    Lilongwe

Other trials in Malawi

United Kingdom1 site
  • Great Ormond Street Hospital NHS Foundation Trust

    London, WC1N 3JH

Other trials in United Kingdom

About this study

Official title: Development of a Robust and Reliable Pulse Oximeter for Use by Frontline Healthcare Providers Caring for Children With Pneumonia in Low-income Countries

This study is to test the usability of a new pulse oximeter probe designed for children 0-5 years.

Read the detailed description

Pneumonia is the leading infectious cause of death in children under five. World Health Organization guidelines recommend measurement of peripheral oxygen saturation (SpO2) in children with pneumonia to guide treatment. This project focuses on the design of a new 'Lifebox' pulse oximeter probe for use in children 0-5 years of age.

A new oximeter probe compatible with the Lifebox oximeter has been designed to be used for children 0-5 years in all settings.

The aims of the study are to:

  1. to evaluate the usability of the redesigned Lifebox oximeter probe by an expert user
  2. to evaluate the usability of the redesigned oximeter probe by trained healthcare workers, against defined product specifications.
  3. to compare the usability of the redesigned oximeter probe to a market leading probe
Being tested
Pulse oximeter
Keywords
Pulse oximetry, Children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulse oximeterDevice

    Time taken to measure oxygen saturation.

    Completion of usability questionnaire

Study groups in NCT02941237
Study groupRoleWhat they receive
Healthcare worker measurement of SpO2OtherMeasurement of SpO2 using the Lifebox pulse oximeter probe in children of different ages, stratified by age: 0-1 months, 2-11 months, 12-23 months and 24-59 months
Receives: Device: Pulse oximeter
Expert measurement of SpO2OtherMeasurement of SpO2 using the Lifebox pulse oximeter probe and Masimo oximeter probe in children of different ages, stratified by age: 0-1 months, 2-11 months, 12-23 months and 24-59 months
Receives: Device: Pulse oximeter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to obtain SpO2 reading

    The time to obtain a stable reading will be declared by the healthcare worker or expert and noted by the independent observer, to give a proportion fulfilling the Target Product Profile (TPP).

    Measured: Through completion of study, average one hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2016 (estimated)
  2. Study start2 May 2017
  3. Primary completion2 Jun 2017
  4. Study completion1 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
572 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02941237
Sponsor's protocol ID
OPP1133291
Status last verified
Mar 2023
First submitted
16 Oct 2016
Last updated
9 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Burn SL, Chilton PJ, Gawande AA, Lilford RJ. Peri-operative pulse oximetry in low-income countries: a cost-effectiveness analysis. Bull World Health Organ. 2014 Dec 1;92(12):858-67. doi: 10.2471/BLT.14.137315. Epub 2014 Sep 24.

    PubMed 25552770
  • Finch LC, Kim RY, Ttendo S, Kiwanuka JK, Walker IA, Wilson IH, Weiser TG, Berry WR, Gawande AA. Evaluation of a large-scale donation of Lifebox pulse oximeters to non-physician anaesthetists in Uganda. Anaesthesia. 2014 May;69(5):445-51. doi: 10.1111/anae.12632.

    PubMed 24738801
  • Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015 Jan 31;385(9966):430-40. doi: 10.1016/S0140-6736(14)61698-6. Epub 2014 Sep 30.

    PubMed 25280870
  • Duke T, Wandi F, Jonathan M, Matai S, Kaupa M, Saavu M, Subhi R, Peel D. Improved oxygen systems for childhood pneumonia: a multihospital effectiveness study in Papua New Guinea. Lancet. 2008 Oct 11;372(9646):1328-33. doi: 10.1016/S0140-6736(08)61164-2. Epub 2008 Aug 15.

    PubMed 18708248
  • Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I, Black RE; Lancet Diarrhoea and Pneumonia Interventions Study Group. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013 Apr 20;381(9875):1417-1429. doi: 10.1016/S0140-6736(13)60648-0. Epub 2013 Apr 12.

    PubMed 23582723
  • Matai S, Peel D, Wandi F, Jonathan M, Subhi R, Duke T. Implementing an oxygen programme in hospitals in Papua New Guinea. Ann Trop Paediatr. 2008 Mar;28(1):71-8. doi: 10.1179/146532808X270716.

    PubMed 18318953
  • Soofi S, Ahmed S, Fox MP, MacLeod WB, Thea DM, Qazi SA, Bhutta ZA. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Lancet. 2012 Feb 25;379(9817):729-37. doi: 10.1016/S0140-6736(11)61714-5. Epub 2012 Jan 27.

    PubMed 22285055
  • Yeboah-Antwi K, Pilingana P, Macleod WB, Semrau K, Siazeele K, Kalesha P, Hamainza B, Seidenberg P, Mazimba A, Sabin L, Kamholz K, Thea DM, Hamer DH. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. PLoS Med. 2010 Sep 21;7(9):e1000340. doi: 10.1371/journal.pmed.1000340.

    PubMed 20877714
  • Faulkner L. Beyond the five-user assumption: benefits of increased sample sizes in usability testing. Behav Res Methods Instrum Comput. 2003 Aug;35(3):379-83. doi: 10.3758/bf03195514.

    PubMed 14587545
  • King C, Boyd N, Walker I, Zadutsa B, Baqui AH, Ahmed S, Islam M, Kainja E, Nambiar B, Wilson I, McCollum ED. Opportunities and barriers in paediatric pulse oximetry for pneumonia in low-resource clinical settings: a qualitative evaluation from Malawi and Bangladesh. BMJ Open. 2018 Jan 30;8(1):e019177. doi: 10.1136/bmjopen-2017-019177.

    PubMed 29382679

Questions about this trial

What is this clinical trial studying?

A study testing Pulse oximeter in people with Pneumonia in Children and Measurement of Peripheral Oxygen Saturation, run by The Lifebox Foundation at 3 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Bangladesh, Malawi, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to obtain SpO2 reading (time frame: Through completion of study, average one hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02941237, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in